Latest COVID-19 Research & Evidence — 12/11/20

 

Worcestershire Health Libraries: 

Latest COVID-19 Research & Evidence — 12/11/20

 

Research

 

Title: Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK

Description: This prospective cohort study provided data on the incidence, characteristics, transmission, and outcomes of SARS-CoV-2 infection in neonates who received inpatient hospital care in the UK.

Available from: https://www.thelancet.com/action/showPdf?pii=S2352-4642%2820%2930342-4

 

Title: Lung volume reduction and infection localization revealed in big data CT imaging of COVID-19

Description: An analysis of 974 diseases which revealed new risk factors for severe COVID-19. Delirium, dementia, amnestic, and other cognitive disorders were some of those risk factors investigated.

Available from: https://www.sciencedirect…6f039ae516&pid=1-s2.0-S0889159120323692-main.pdf

 

Title: Kidney involvement in COVID-19 and its treatments

Description: A review and discussion of existing literature on COVID-19 infection in combination with kidney diseases in terms of kidney damage, pathogenesis, and treatment to guide clinical antiepidemic responses.

Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26653

 

Guidance

 

Title: COVID-19 rapid guideline: delivery of systemic anticancer treatments (Updated 09/11/20)

Description: The purpose of this guideline is to maximise the safety of patients with cancer and make the best use of NHS resources during the COVID-19 pandemic, while protecting staff from infection.

Available from: https://www.nice.org.uk/guidance/ng161

 

Title: COVID-19 and the management of patients with inflammatory bowel disease

Description: A ‘decalogue’ of practical recommendations for gastroenterologists to manage patients with IBD in the post-peak phase of the COVID-19 pandemic.

Available from: https://journals.sagepub.com/doi/pdf/10.1177/1756284820968747

 

Expert Opinions

 

Title: Vaccine candidate may be more than 90% effective, interim results indicate

Description: A vaccine candidate developed by Pfizer and BioNTech may be more than 90% effective in preventing COVID-19 in participants without prior infection. This BMJ news piece details the trial and its future developments.

Available from: https://www.bmj.com/content/bmj/371/bmj.m4347.full.pdf

 

Title: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?

Description: The urgent need for covid-19 vaccines has prompted thousands of otherwise healthy people to volunteer to be infected with the virus to test candidate vaccines. The authors discuss in this opinion ‘head-to-head’.

Available from: https://www.bmj.com/content/bmj/371/bmj.m4258.full.pdf

For additional support with accessing the publications above, visit www.wkp.nhs.uk